Marque Millennium Capital Management’s Zimmer Biomet ZBH Stock Holding History

Marque Millennium Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.22M	Sell	13,339 -8,549	-39%	-$857K	0.87%	50
2015 Q2	$2.32M	Sell	21,888 -8,034	-27%	-$889K	1.18%	39
2015 Q1	$3.41M	Hold	29,922	–	–	1.34%	31
2014 Q4	$3.29M	Hold	29,922	–	–	1.3%	31
2014 Q3	$2.92M	Hold	29,922	–	–	1.18%	38
2014 Q2	$3.02M	Hold	29,922	–	–	1.2%	37
2014 Q1	$2.75M	Hold	29,922	–	–	1.15%	39
2013 Q4	$2.71M	Hold	29,922	–	–	1.19%	37
2013 Q3	$2.39M	Hold	29,922	–	–	1.18%	37
2013 Q2	$2.18M	Buy	+29,922	New	+$2.24M	1.15%	42

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Marque Millennium Capital Management's ZBH Position: Q3 2015 in Review

Marque Millennium Capital Management reduced its Zimmer Biomet (ZBH) stake by 39% in Q3 2015, selling an estimated $857K and leaving 13,339 shares worth $1.22M. The position accounts for 0.87% of the portfolio, ranked #50.

Marque Millennium Capital Management first reported a position in ZBH in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.41M in Q1 2015. 726 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Marque Millennium Capital Management held 13,339 shares of Zimmer Biomet worth $1.22M as of Q3 2015.
Marque Millennium Capital Management sold 8,549 Zimmer Biomet shares in Q3 2015, an estimated $857K.
Zimmer Biomet made up 0.87% of Marque Millennium Capital Management's portfolio in Q3 2015, its #50 holding.
Marque Millennium Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 10 quarters since.
Marque Millennium Capital Management's Zimmer Biomet position peaked at $3.41M in Q1 2015.
726 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Marque Millennium Capital Management's 13F filing for Q3 2015, filed 3 Nov 2015.